Evaluation of the safety profile of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients receiving uninterrupted bevacizumab-based systemic chemotherapy: A retrospective analysis from a high-volume tertiary centre

Surgical Oncology Insight · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles